학술논문
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
Document Type
Article
Author
Source
In The Lancet 2010 376(9739):431-439
Subject
Language
ISSN
0140-6736